Your browser doesn't support javascript.
loading
AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer.
Oar, Andrew; Lee, Mark; Le, Hien; Wilson, Kate; Aiken, Chris; Chantrill, Lorraine; Simes, John; Nguyen, Nam; Barbour, Andrew; Samra, Jaswinder; Sjoquist, Katrin M; Moore, Alisha; Espinoza, David; Gebski, Val; Yip, Sonia; Chu, Julie; Kneebone, Andrew; Goldstein, David.
Afiliación
  • Oar A; Icon Cancer Centre, Gold Coast University Hospital, Gold Coast, Australia. andrew.oar@icon.team.
  • Lee M; Liverpool and Macarthur Cancer Therapy Centres, Sydney, Australia.
  • Le H; Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, Australia.
  • Wilson K; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
  • Aiken C; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
  • Chantrill L; Wollongong Hospital, Wollongong, Australia.
  • Simes J; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
  • Nguyen N; Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide, Adelaide, Australia.
  • Barbour A; Princess Alexandra Hospital, Brisbane, Australia.
  • Samra J; Royal North Shore Hospital, Sydney, Australia.
  • Sjoquist KM; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
  • Moore A; Cancer Care Centre, St George Hospital, Kogarah, Australia.
  • Espinoza D; Trans-Tasman Radiation Oncology Group, Newcastle, Australia.
  • Gebski V; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
  • Yip S; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
  • Chu J; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
  • Kneebone A; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Goldstein D; Department of Radiation Oncology Royal North Shore Hospital Sydney Australia and University of Sydney, Sydney, Australia.
BMC Cancer ; 21(1): 936, 2021 Aug 19.
Article en En | MEDLINE | ID: mdl-34412605
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Radiocirugia Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Radiocirugia Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Australia